AnaBios Boosts Discovery of Safer, More Effective Medicines With License From the University of Louisville SAN DIEGO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- AnaBios, a preclinical contract research organization that provides ex vivo human platforms to de-risk new drugs, today announced a technology transfer...

AnaBios Announces Inaugural Translational Research Conference to Be Held in San Diego SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- AnaBios today announced the inaugural Translational Research Conference to be held Feb. 27-28, 2023, in San Diego, California. The conference will gather...

AnaBios Further Expands Business Development Team With Hiring of Dr. Blake Anson SAN DIEGO, June 14, 2022 (GLOBE NEWSWIRE) -- AnaBios is pleased to announce the hire of Blake Anson, Ph.D., as Vice President of Business Development. In this new role, Dr. Anson will contribute to...